Fenoterol

Jump to: navigation, search
Fenoterol
File:Fenoterol.svg
Clinical data
Routes of
administration
Inhaled
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC17H21NO4
Molar mass303.35 g/mol

WikiDoc Resources for Fenoterol

Articles

Most recent articles on Fenoterol

Most cited articles on Fenoterol

Review articles on Fenoterol

Articles on Fenoterol in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Fenoterol

Images of Fenoterol

Photos of Fenoterol

Podcasts & MP3s on Fenoterol

Videos on Fenoterol

Evidence Based Medicine

Cochrane Collaboration on Fenoterol

Bandolier on Fenoterol

TRIP on Fenoterol

Clinical Trials

Ongoing Trials on Fenoterol at Clinical Trials.gov

Trial results on Fenoterol

Clinical Trials on Fenoterol at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Fenoterol

NICE Guidance on Fenoterol

NHS PRODIGY Guidance

FDA on Fenoterol

CDC on Fenoterol

Books

Books on Fenoterol

News

Fenoterol in the news

Be alerted to news on Fenoterol

News trends on Fenoterol

Commentary

Blogs on Fenoterol

Definitions

Definitions of Fenoterol

Patient Resources / Community

Patient resources on Fenoterol

Discussion groups on Fenoterol

Patient Handouts on Fenoterol

Directions to Hospitals Treating Fenoterol

Risk calculators and risk factors for Fenoterol

Healthcare Provider Resources

Symptoms of Fenoterol

Causes & Risk Factors for Fenoterol

Diagnostic studies for Fenoterol

Treatment of Fenoterol

Continuing Medical Education (CME)

CME Programs on Fenoterol

International

Fenoterol en Espanol

Fenoterol en Francais

Business

Fenoterol in the Marketplace

Patents on Fenoterol

Experimental / Informatics

List of terms related to Fenoterol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Fenoterol is an asthma medication designed to open up the airways to the lungs. It is classed as a beta agonist.

It was a long-acting beta-agonist widely used in New Zealand in the early 1990s but withdrawn because of its association with an excess number of deaths.

References

  • Beasley R, Pearce N, Crane J, Burgess C. Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic. Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):325-7.
  • Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992 Feb 20, 1992;326(8):501-6.


de:Fenoterol


Linked-in.jpg